Indications for implantable cardioverter defibrillator therapy

Heart Disease

Volumn 4, Issue 3, 2002, Pages 166-170

  Sorbera, Carmine A ^a   Cusack, Evelyn J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; PROPAFENONE; SOTALOL;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART DILATATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; META ANALYSIS; REVIEW; TREATMENT INDICATION; FEMALE; FOLLOW UP; HEART ARREST; HOSPITALIZATION; MALE; MORTALITY; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL; TREATMENT OUTCOME;

CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0036082756     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200205000-00007     Document Type: Review

References (23)

1. Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias
2. Mortality in patients with implanted automatic defibrillators
3. Guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: A report of the ACC/AHA Task Fotceon assessment of diagnostic and therapeutic cardiovascular procedures (committee on pacemaker implantation)
4. Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and ElectrophysioIogy
5. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias
6. ICD versus drugs in cardiac arrest survivors: Preliminary results of the cardiac arrest study Hamburg (CASH)
7. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The cardiac arrest study Hamburg (CASH)
8. Canadian Implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter against amiodarone
9. Relative effectiveness of the implantable cardioverter defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricuIar arrhythmias
10. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. The Canadian implantable defibrillator study
11. Clinical characteristics and outcome of patients with high defibrillation thresholds-A multicenter study
12. A randomized study of the prevention of sudden death in patients with coronary artery disease
13. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden deatb
14. Prophylactic implantation of a defibrillator in patents with myocardial infarction and reduced ejection fraction
15. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
16. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
17. Polymorphic ventricular tachycardia, long QT syndrome, and torsades de pointes
18. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts
19. Right bundle branch block and ST segment elevation in leads V1-V3. A marker for sudden death in patients with no demonstrable structural heart disease
20. Early benefit of imptantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation
21. Syncope is a strong predictor of sudden cardiac death in patients listed for heart transplantation
22. Initial clinical experience with an implantable human atrial defibrillator